Analysis of the microvasculature and tissue type ratios in normal vs. benign and malignant breast tissue

Analytical and Quantitative Cytology and Histology

Volumn 26, Issue 3, 2004, Pages 166-174

  Wells, Wendy A ^a,g   Daghlian, Charles P ^b,c   Tosteson, Tor D ^d   Grove, Margaret R ^a   Poplack, Steven P ^a   Knowlton Soho, Sandra ^e   Paulsen, Keith D ^f  

^a Department of Pathology ^*

^b Electron Microscope Facility

^c Biol Sci Earth Sci and Pathol   (United States)

^d Dept of Comm and Family Medicine   (United States)

^e Office of Women's Health Research

^f DARTMOUTH COLLEGE   (United States)

^g DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Breast neoplasms; Computer assisted; Immunohistochemistry; Reproducibility of results

Indexed keywords

ADULT; ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST CARCINOMA; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM; FEMALE; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN TISSUE; HYALINE DEGENERATION; IMAGING; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROVASCULATURE; MORPHOLOGY; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; STROMA; TISSUE TYPES;

ADULT; BREAST; BREAST NEOPLASMS; DIAGNOSIS, COMPUTER-ASSISTED; FIBROADENOMA; FIBROCYSTIC BREAST DISEASE; HUMANS; MIDDLE AGED; NEOPLASM STAGING;

EID: 2942520982     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Gotzsche P, Olsen O: Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-134
2. Gotzsche P, Olsen O: Cochrane review on screening for breast cancer with mammography. Lancet 2001;358: 1340-1342
3. Fletcher S, Black W, Harris R, Rimer B, Shapiro S: Report of the International Workshop for Breast Cancer. J Natl Cancer Inst 1993;85:1644-1656
4. Elmore J, Barton M, Moceri V, Polk S, Arena P, Fletcher S: Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998;338: 1089-1096
5. Brown M, Houn F, Sickles E, Kessler L: Screening mammography in community practice. AJR AM J Roentgenol 1995; 165:1373-1377
6. Rosenberg RD, Lando JF, Hunt WC, Darling RR, Williamson MR, Linver MN, Gilliland FD, Key CR: The New Mexico Mammography Project: Screening mammography performance in Albuquerque, New Mexico, 1991 to 1993. Cancer 1996;78:1731-1739
7. Poplack S, Tosteson A, Grove M, Wells W, Carney P: Mammography in 58,803 women from the New Hampshire Mammography Network. Radiology 2000;217:832-840
8. Franceschini MA, Moesta KT, Fantini S, Gaida G, Gratton E, Jess H, Mantulin WW, Seeber M, Schlag PM, Kaschke M: Frequency domain techniques enhance optical mammography: Initial clinical results. Proc Natl Acad Sci 1997;94:6468-6473
9. Pogue BW, Poplack SP, McBride TO, Wells WA, Osterberg UL, Paulsen KD: Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: Pilot results in the breast. Radiology 2001;218:261-266
10. Shah N, Cerussi A, Eker C, Espinoza J, Butler J, Fiskin J, Hornung R, Tromberg B: Noninvasive functional optical spectroscopy of human breast tissue. Proc Natl Acad Sci 2001; 98:4420-4425
11. Sinkus R, Lorenzen J, Schrader D, Lorenzen M, Dargatz M, Holz D: MR-elastography applied to in vivo MR-mammography. In Proc of 7th Scientific Meeting of the International Society for Magnetic Resonance in Medicine, Philadelphia, May 22-28, 1999, p 259
12. McKnight AL, Kugel JL, Rossman PJ, Manduca A, Hartmann LC, Ehman RL: MR elastography of breast cancer: Preliminary results. Amer J Roentgenol 2002;178:1411-1417
13. Van Houten EEW, Doyley MM, Kennedy FE, Weaver JB, Paulsen KD: Initial in vivo experience with steady-state subzone-based MR elastography of the human breast. J Magn Res Imag 2003;17:72-85
14. Kruger RA, Miller KD, Reynolds HE, Kiser WL, Reinecke Dr, Kruger GA: Breast cancer in vivo: Contrast enhancement with thermoacoustic CT at 434 MHz: Feasibility study. Radiology 2000;216:279-282
15. Malich A, Fritsch T, Anderson R, Boehm, Freesmeyer MG, Fleck M, Kaiser WA: Electrical impedance scanning for classifying suspicious breast lesions: First results. Eur Radiol 2000;10:1555-1561
16. Poplack SP, Paulsen KD, Hartov A, Meaney PM, Pogue BW, Tosteson TD, Grove MR, Soho SK, Wells W: Electromagnetic breast imaging: Average tissue properties in normal women. Radiology 2004;231:571-580
17. Marino A, Iliev I, Schwalke M, Gonzales E, Maler K, Flanagan C: Association between cell membrane potential and cancer. Tumour Biol 1994;15:82-89
18. Chaudhary S, Mishra R, Swarup A, Thomas J: Dielectric properties of normal and malignant human breast tissues at radiowave and microwave frequencies. Indian J Biochem Biophys 1984;21:76-79
19. Morimoto T, Kimura S, Konishi Y: A study of the electrical bio-impedance of tumors. J Invest Surg 1993;6:25-32
20. Jossinet J: Variability of impedivity in normal and pathological breast tissue. Med Biol Eng Comput 1996;34:346-350
21. Surowiec A, Stuchly S, Barr J, Swarup A: Dielectric properties of breast carcinoma and the surrounding tissues. IEEE Trans Biomed Eng 1988;35:257-263
22. Joines W, Zhang Y, Li C, Jirtle R: The measured electrical properties of normal and malignant human tissues from 50 to 90 Mhz. Med Phys 1994;21:547-550
23. Huynh P, Jarolimek A, Daye S: The false-negative mammogram. Radiographics 1998;18:1137-1154
24. Jackson V, Hendrick R, Feig S, Kopans D: Imaging of the radiographically dense breast. Radiology 1993;188:297-301
25. Bird R, Wallace T, Yankaskas B: Analysis of cancers missed at screening mammography. Radiology 1992;184:613-617
26. Sickles E, Ominsky S, Sollitto R, Galvin D, Monticciolo D: Medical audit of a rapid throughput mammography screening practice: Methodology and results of 27,114 examinations. Radiology 1990;175:323-327
27. Beam C, Layde P, Sullivan D: Variability in the interpretation of screening mammography by U.S. radiologists. Arch Intern Med 1996;156:209-212
28. Goulding H, Nik Abdul Rashid N, Robertson J, Blamey R, Ellis I: Assessment of angiogenesis in breast carcinoma: An important factor in prognosis? Hum Pathol 1995;26:1196-1200
29. Santinelli A, Baccarini M, Colanzi P, Fabris G: Microvessel quantitation in intraductal and early invasive breast carcinomas. Analyt Quant Cytol Histol 2000;2:277-284
30. Weind K, Maier C, Rutt B, Moussa M: Invasive carcinomas and fibroadenomas of the breast: Comparison of microvessel distributions: Implications for imaging modalities. Radiology 1998;208:477-483
31. Weidner N, Semple J, Welch WR, Folkman J: Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8
32. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred DC, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887
33. Fox S, Turner GDH, Leek R, Whitehouse R, Gatter K, Harris A: The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium. Breast Cancer Res Treat 1995;36: 219-226
34. Simpson J, Ahn C, Battifora H, Esteban J: Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer 1996;77:2077-2085
35. Kohlberger P, Obermair A, Sliutz G, Heinzl H, Koelbl H, Breitenecker G, Gitsch G, Kainz C: Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: A comparison of computer-assisted image analysis with established counting methods. Am J Clin Pathol 1996;105:705-710
36. Cruz D, Valenti C, Dias A, Seixas M, Schmitt F: Microvessel density counting in breast cancer: Slides versus digital images. Analyt Quant Cytol Histol 2001;23:15-20
37. Samoszuk M, Leonor L, Espinoza F, Carpenter P, Nalcioglu O, Su M-V: Measuring microvascular density in tumors by digital dissection. Analyt Quant Cytol Histol 2002;24:15-22
38. King T, Brey E, Youssef A, Johnston C, Patrick C: Quantification of vascular density using a semiautomated technique for immunostained specimens. Analy Quant Cytol Histol 2002;24:39-48
39. Laforga J, Aranda F: Angiogenic index: A new method for assessing microvascularity in breast carcinoma with possible prognostic implications. Breast J 2000;6:103-107
40. Lee J, Kim H, Jung J, Kim Y, Park C, Lee M: Correlation between angiogenesis, apoptosis and cell proliferation in invasive ductal carcinoma of the breast and their relation to tumor behavior. Analyt Quant Cytol Histol 2001;23:161-168
41. Barbareschi M, Weidner N, Gasparini G, Morelli L, Forti S, Eccher C, Fina P, Caffo O, Leonardi E, Mauri F, Bevilacqua P, Palma PD: Microvessel density quantification in breast carcinomas. Appl Immunohistochem 1995;3:75-84
42. Vermeulen P, Gasparini G, Fox S, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY: Quantification of angiogenesis in solid human tumors: An international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996;32A:2474-2484
43. Kumar S, Ghellal A, Li C, Byrne G, Haboubi N, Wang JM, Bundred N: Breast carcinoma: Vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 1999;59:856-861